Among people with Sjögren’s disease, those diagnosed before age 45 may face an increased risk of unusually high antibody levels in the blood and chronic lung disease, according to a study of more than 5,000 patients in China. Researchers linked these features to a distinct pattern of immune cells…
Discussion
A self-perpetuating loop where T-cells and B-cells continuously activate each other may contribute to the development of Sjögren’s disease, according to a cell-based study that uncovers a potential new target for selective therapies. Led by scientists at Keio University School of Medicine, in Tokyo, Japan, a research team analyzed…
Discussion
Efgartigimod, a treatment approved for certain autoimmune diseases, was linked to maintained clinical responses and low disease activity scores for up to 72 weeks in people with Sjögren’s disease, according to data from a small Phase 2 clinical trial and its open-label extension study. Participants who showed a clinical…
Discussion
People with primary Sjögren’s disease and their close family members have a higher risk of developing cancer than the general population, according to a study out of Turkey. While Sjögren’s has been associated with a higher risk of cancer, the potential risk among family members is a new…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
